These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 33704350)

  • 1. Hyperuricemia and chronic kidney disease: to treat or not to treat.
    Piani F; Sasai F; Bjornstad P; Borghi C; Yoshimura A; Sanchez-Lozada LG; Roncal-Jimenez C; Garcia GE; Hernando AA; Fuentes GC; Rodriguez-Iturbe B; Lanaspa MA; Johnson RJ
    J Bras Nefrol; 2021; 43(4):572-579. PubMed ID: 33704350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function.
    Zoppini G; Targher G; Chonchol M; Ortalda V; Abaterusso C; Pichiri I; Negri C; Bonora E
    Diabetes Care; 2012 Jan; 35(1):99-104. PubMed ID: 22028277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperuricemia has increased the risk of progression of chronic kidney disease: propensity score matching analysis from the KNOW-CKD study.
    Oh TR; Choi HS; Kim CS; Bae EH; Ma SK; Sung SA; Kim YS; Oh KH; Ahn C; Kim SW
    Sci Rep; 2019 Apr; 9(1):6681. PubMed ID: 31040373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uric Acid and the Risks of Kidney Failure and Death in Individuals With CKD.
    Srivastava A; Kaze AD; McMullan CJ; Isakova T; Waikar SS
    Am J Kidney Dis; 2018 Mar; 71(3):362-370. PubMed ID: 29132945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uric acid and chronic kidney disease: which is chasing which?
    Johnson RJ; Nakagawa T; Jalal D; Sánchez-Lozada LG; Kang DH; Ritz E
    Nephrol Dial Transplant; 2013 Sep; 28(9):2221-8. PubMed ID: 23543594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time to target uric acid to retard CKD progression.
    Kumagai T; Ota T; Tamura Y; Chang WX; Shibata S; Uchida S
    Clin Exp Nephrol; 2017 Apr; 21(2):182-192. PubMed ID: 27339448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperuricemia and Progression of CKD in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort Study.
    Rodenbach KE; Schneider MF; Furth SL; Moxey-Mims MM; Mitsnefes MM; Weaver DJ; Warady BA; Schwartz GJ
    Am J Kidney Dis; 2015 Dec; 66(6):984-92. PubMed ID: 26209544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal Effects of Hyperuricemia.
    Méndez Landa CE
    Contrib Nephrol; 2018; 192():8-16. PubMed ID: 29393089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral uricase eliminates blood uric acid in the hyperuricemic pig model.
    Szczurek P; Mosiichuk N; Woliński J; Yatsenko T; Grujic D; Lozinska L; Pieszka M; Święch E; Pierzynowski SG; Goncharova K
    PLoS One; 2017; 12(6):e0179195. PubMed ID: 28594873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperuricemia and chronic kidney disease: an enigma yet to be solved.
    Dousdampanis P; Trigka K; Musso CG; Fourtounas C
    Ren Fail; 2014 Oct; 36(9):1351-9. PubMed ID: 25112538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of hyperuricemia in chronic kidney disease].
    Schwotzer N; Auberson M; Livio F; So A; Bonny O
    Rev Med Suisse; 2022 Mar; 18(771):379-384. PubMed ID: 35235261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urate-lowering agents for asymptomatic hyperuricemia in stage 3 - 4 chronic kidney disease: Controversial role of kidney function.
    Jeon HJ; Oh J; Shin DH
    PLoS One; 2019; 14(6):e0218510. PubMed ID: 31206563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hyperuricemia on incident renal replacement therapy and all-cause mortality among patients with chronic kidney disease stages 3-5: a retrospective cohort study.
    Lee CL; Wang JS
    Sao Paulo Med J; 2019; 137(6):523-529. PubMed ID: 32159639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperuricemia in Kidney Disease: A Major Risk Factor for Cardiovascular Events, Vascular Calcification, and Renal Damage.
    Ejaz AA; Nakagawa T; Kanbay M; Kuwabara M; Kumar A; Garcia Arroyo FE; Roncal-Jimenez C; Sasai F; Kang DH; Jensen T; Hernando AA; Rodriguez-Iturbe B; Garcia G; Tolan DR; Sanchez-Lozada LG; Lanaspa MA; Johnson RJ
    Semin Nephrol; 2020 Nov; 40(6):574-585. PubMed ID: 33678312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mini Review: Reappraisal of Uric Acid in Chronic Kidney Disease.
    Goldberg A; Garcia-Arroyo F; Sasai F; Rodriguez-Iturbe B; Sanchez-Lozada LG; Lanaspa MA; Johnson RJ
    Am J Nephrol; 2021; 52(10-11):837-844. PubMed ID: 34673651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of uric acid in kidney fibrosis: experimental evidences for the causal relationship.
    Kim IY; Lee DW; Lee SB; Kwak IS
    Biomed Res Int; 2014; 2014():638732. PubMed ID: 24877124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project.
    Russo E; Viazzi F; Pontremoli R; Barbagallo CM; Bombelli M; Casiglia E; Cicero AFG; Cirillo M; Cirillo P; Desideri G; D'Elia L; Ferri C; Galletti F; Gesualdo L; Giannattasio C; Iaccarino G; Leoncini G; Mallamaci F; Maloberti A; Masi S; Mengozzi A; Mazza A; Muiesan ML; Nazzaro P; Palatini P; Parati G; Rattazzi M; Rivasi G; Salvetti M; Tikhonoff V; Tocci G; Ungar A; Verdecchia P; Virdis A; Volpe M; Grassi G; Borghi C;
    J Nephrol; 2022 Jan; 35(1):211-221. PubMed ID: 33755930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymptomatic hyperuricemia and cardiovascular mortality in patients with chronic kidney disease who progress to hemodialysis.
    Petreski T; Ekart R; Hojs R; Bevc S
    Int Urol Nephrol; 2019 Jun; 51(6):1013-1018. PubMed ID: 31020628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperuricemia, Hypertension, and Chronic Kidney Disease: an Emerging Association.
    Mallat SG; Al Kattar S; Tanios BY; Jurjus A
    Curr Hypertens Rep; 2016 Oct; 18(10):74. PubMed ID: 27696189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uric acid: association with rate of renal function decline and time until start of dialysis in incident pre-dialysis patients.
    Nacak H; van Diepen M; de Goeij MC; Rotmans JI; Dekker FW;
    BMC Nephrol; 2014 Jun; 15():91. PubMed ID: 24939671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.